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ABSTRACT: The use of serologic assays for
influenza A virus (IAV) surveillance in wild
birds has increased because of the availability of
commercial enzyme-linked immunosorbent as-
says (ELISAs). Recently, an H5-specific block-
ing ELISA (bELISA) was shown to reliably
detect H5-specific antibodies to low- and high-
pathogenic H5 viruses in experimentally infect-
ed waterfowl. Mute Swans (Cygnus olor) were
frequently associated with highly pathogenic
H5N1 outbreaks in Europe and may have
a similar role if highly pathogenic H5N1 is
introduced into North America. We measured
the prevalence of antibodies to the nucleopro-
tein and H5 protein in Mute Swans using
three serologic assays. We collected 340 serum
samples from Mute Swans in Michigan, New
Jersey, New York, and Rhode Island, US. We
detected antibodies to the IAV nucleoprotein in
66.2% (225/340) of the samples. We detected
H5-specific antibodies in 62.9% (214/340) and
18.8% (64/340) using a modified H5 bELISA
protocol and hemagglutination inhibition (HI)
assay, respectively. The modified H5 bELISA
protocol detected significantly more positive
samples than did the manufacturer’s protocol.
We also tested 46 samples using virus neutral-
ization. Neutralization results had high agree-
ment with the modified H5 bELISA protocol
and detected a higher prevalence than did the
HI assay. These results indicate that North
American Mute Swans have high nucleoprotein
and H5 antibody prevalences.
Key words: Cygnus olor, H5-specific
ELISA, hemagglutination inhibition, Mute
Swan, serology.
Surveillance for influenza A viruses
(IAVs) in wild birds has traditionally been
based on detection of viral shedding using
virus isolation or PCR. However, recently,
there has been an increase in the use of
serologic assays for IAV surveillance because
of the development and validation of several
commercially available enzyme-linked im-
munosorbent assays (ELISAs) in several wild
bird species (Brown et al. 2009). These
commercial assays detect antibodies to the
IAV nucleoprotein (NP) and have been
effectively used for IAV surveillance in wild
birds (Brown et al. 2010; Kistler et al. 2012).
However, the commercial assays validated
for use in wild birds detect antibodies to all
IAVs and not subtype-specific antibodies.
Historically, hemagglutination inhibi-
tion (HI) has been the most frequently
used assay to detect subtype-specific
antibodies in wild birds (Winkler et al.
1972). The HI assay can detect IAV
antibodies in multiple species and has been
used in large-scale surveillance studies
(Niqueux et al. 2010). However, there are
disadvantages to the HI assay; the most
important of which is a lack of standardi-
zation of antigen and antisera across
laboratories, making it difficult to compare
results among studies (Stephenson et al.
2007). The development of a blocking
ELISA (bELISA) with high sensitivity
and specificity for H5-specific antibodies
in experimentally infected Mallards (Anas
platyrhynchos; Lebarbenchon et al. 2013)
offers the potential for standardization of
results across laboratories.
The emergence of highly pathogenic
(HP) H5N1 in poultry in 1997 resulted in
an increase in the availability of H5-
523
specific antibody tests. During the past
15 yr, HP H5N1 viruses have been
reported in wild birds across Asia and
Europe. In particular, Mute Swans (Cyg-
nus olor) were frequently associated with
outbreaks in Europe (Feare 2010). Mute
Swans may play a role if HP H5N1 is
introduced to North America. We tested
Mute Swans in the US for H5 IAV
antibodies using three H5-specific sero-
logic assays.
Blood samples were collected from Mute
Swans (n5340) in collaboration with the
US Department of Agriculture (USDA),
Animal and Plant Health Inspection Ser-
vice, during wildlife damage management
operations in Michigan, New Jersey, New
York, and Rhode Island, US. Blood samples
were collected postmortem from the jugu-
lar vein or by cardiocentesis within 2 h of
euthanasia, were placed in VacutainerH
tubes (Becton Dickinson, Franklin Lakes,
New Jersey, USA), and were kept cold in
the field. Samples were centrifuged for
15 min at 1,500 3 G, and sera were stored
at 220 C until testing.
Antibodies to all IAV serotypes were
detected using a commercial NP bELISA
(IDEXX Laboratories, Westbrook, Maine,
USA) per manufacturer’s instructions
(Brown et al. 2009). We detected H5-
specific antibodies using three assays: 1)
bELISA (ID VET, Montpelier, France);
2) H5 HI assay; and 3) an H5 virus
microneutralization (MN) assay. We used
two protocols with the H5-specific bE-
LISA: 1) the manufacturer’s protocol, and
2) a modified protocol using a 1:2 serum
dilution with an 18-h incubation at 36 C
(Lebarbenchon et al. 2013). We tested 182
serum samples with both H5 bELISA
protocols, and the remaining 158 samples
with only the modified H5 ELISA proto-
col. Samples with sample to negative ratios
.0.35 were considered negative. We
tested all 340 serum samples with the HI
assay using A/mallard/AI08-3532/H5N2 as
the antigen and antisera obtained from the
USDA National Veterinary Service Labo-
ratories (Ames, Iowa, USA). Serum sam-
ples were treated with receptor-destroying
enzyme (RDE [II] Denka Seiken, Tokyo,
Japan) at a 1:3 dilution and incubated for
18 h at 36 C and 56 C for 1 h. The HI
assay was performed as described (Ped-
ersen 2008) using four hemagglutination
units per 25 mL of antigen, and a titer $
eight was considered positive (Curran et
al. 2014). We tested 46 serum samples
using the MN assay as described by
Ramey et al. (2014) using low-pathogenic
A/mallard/MN/AI11-3933/2011(H5N1) vi-
rus.
Statistical analyses were conducted with
R version 3.0 (R Development Core Team
2014). Agreement between the two H5
bELISA protocols was evaluated using k
statistics and percentage of agreement.
Interpretation of the k value was based on
the criteria of Landis and Koch (1977).
We used McNemar’s x2 to test for a
significant difference in the number of
positive samples detected among the
assays.
We detected NP antibodies in 66.2%
of serum samples using the NP bELISA
(Table 1). In a comparison of the two H5
bELISA protocols, we detected antibod-
ies in 33.0% (60/182) of the birds using
the manufacturer’s protocol and in 69.2%
(126/182) using the modified protocol.
There was 62% agreement between the
two H5 bELISA protocols with moderate
agreement (k50.3; 95% confidence in-
terval50.1–0.5); the modified protocol
detected significantly more positive sam-
ples than did the manufacturer’s protocol
(McNemar’s x2563; P,0.001). Com-
pared with the two H5 bELISA proto-
cols, we detected a relatively low preva-
lence with the HI assay (Table 1).
Therefore, we tested a subset (n546) of
samples with the MN assay. The 46
samples were selected based on HI
results (23 negatives and 23 positives) to
evaluate the efficacy of the tests and do
not accurately represent the study popu-
lation. The H5 antibody prevalence for
this subset was 65% (30/46) using the
MN assay and the modified H5 bELISA
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protocol and 50% (23/46) using the HI
assay.
The high IAV NP antibody prevalence
we detected in Mute Swans was similar to
the 45% prevalence reported by Pederson
et al. (2014). This high antibody preva-
lence is likely related to the persistence of
antibodies, which may be .1 yr in the
absence of virus circulation (Fereidouni et
al. 2010), and age of the sampled birds
because Mute Swans are a long-lived
waterfowl species (Reese 1980). The high
prevalence of H5-specific antibodies was
unexpected because H5 IAVs are not
frequently reported from waterfowl in
North America (Wilcox et al. 2011). A
similarly high H5 antibody prevalence was
reported in Mute Swans in France (Ni-
queux et al. 2010). The higher prevalence
of H5-specific antibodies, compared with
NP antibodies, in New Jersey may be
related to increased persistence of sub-
type-specific antibodies (Burger et al.
2012).
Lebarbenchon et al. (2013) detected an
increased sensitivity with the H5 bELISA
using the modified H5 bELISA protocol
in experimentally infected ducks. The data
from our study also suggest that the
modified protocol for the H5 bELISA
has increased sensitivity for detection of
H5-specific antibodies in Mute Swans and
possibly other birds. The low prevalence
detected with the HI assay was surprising
because Niqueux et al. (2010), in France,
detected H5-specific antibodies in .45%
of Mute Swans using the HI assay.
However, the HI assay has performed
poorly in experimentally infected Mute
Swans (Kalthoff et al. 2008) and did not
detect antibodies in naturally exposed
sentinel ducks (Globig et al. 2013). The
data from the MN assay were similar to
those from the modified H5 bELISA
protocol; both detected a higher preva-
lence of antibodies than did the HI assay.
Increased sensitivity of the MN assay
compared with the HI assay has been
reported in detection of H5 antibodies
(Rowe et al. 1999). In addition, HI is likely
not the most sensitive assay to detect
subtype-specific antibodies in Mute Swans
and, if used, confirmatory assays should be
performed.
Our results suggest that Mute Swans in
the US have high NP and H5 antibody
prevalences. The significance of this high
prevalence is unknown, but if this reflects
high existing population immunity to H5
viruses, the probability of disease or
successful introduction of highly patho-
genic H5N1 viruses to the US may be low.
Alternatively, these antibodies may protect
Mute Swans from disease associated with
highly pathogenic H5N1 viruses and allow
these to circulate without noticeable
mortality.
Funding was provided by the Depart-
ment of Homeland Security, Center of
Excellence for Emerging and Zoonotic
Animal Diseases cooperative agreement
2010-ST-061-AG0001-02 and contract
HHSN266200700007C from the National
Institute of Allergy and Infectious Diseas-
es, National Institutes of Health (NIH),
Department of Health and Human Ser-
TABLE 1. Prevalence of influenza A virus antibodies to the nucleoprotein (NP) and to the H5-subtype in








Michigan 145/182 (79.7) 136/182 (74.7) 28/182 (15.4)
New Jersey 12/68 (18) 27/40 (67) 10/68 (15)
New York 11/12 (92) 9/12 (75) 3/12 (25)
Rhode Island 57/78 (73) 42/78 (54) 23/78 (29)
Total 225/340 (66.2) 214/340 (62.9) 64/340 (18.8)
a bELISA 5 blocking enzyme-linked immunosorbent assay.
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